HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Monoclonal antibody E6G6 recognizes glycolipids as a differentiation antigen in Shope carcinoma cells.

Abstract
Monoclonal antibody E6G6 preferentially reacted with well differentiated and non-tumorigenic Shope carcinoma cell lines but hardly reacted with undifferentiated and tumorigenic lines as determined by enzyme-linked immunosorbent assay, cytofluorometry and the complement dependent cytotoxicity test. Immunohistochemical analysis of the primary carcinoma tissue revealed that the antibody intensely stained keratinizing carcinoma cells with marked shrinkage whereas it did not stain normal epidermal keratinizing rabbit cells or benign tumor (Shope papilloma) cells, suggesting that the antigen expression in vivo was closely correlated with terminal differentiation of the carcinoma cells. Thin layer chromatography immunostaining revealed that the antigen was comprised of several neutral glycolipids and that differentiated cells contained about ten times more antigen than undifferentiated cells.
AuthorsM Kyogashima, M Inoue, T Isono, J Nakayama, A Seto
JournalCancer letters (Cancer Lett) Vol. 81 Issue 2 Pg. 221-8 (Jun 30 1994) ISSN: 0304-3835 [Print] Ireland
PMID8012941 (Publication Type: Journal Article)
Chemical References
  • Antibodies, Monoclonal
  • Antigens, Differentiation
  • Antigens, Neoplasm
  • Glycolipids
Topics
  • Animals
  • Antibodies, Monoclonal (immunology)
  • Antigens, Differentiation (analysis)
  • Antigens, Neoplasm (analysis)
  • Carcinoma, Squamous Cell (immunology)
  • Chromatography, Thin Layer
  • Cottontail rabbit papillomavirus
  • Cytotoxicity, Immunologic
  • Female
  • Glycolipids (analysis)
  • Immunohistochemistry
  • Mice
  • Mice, Inbred BALB C
  • Rabbits
  • Tumor Cells, Cultured
  • Tumor Virus Infections (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: